Reversal of Sensorimotor Gating Deficits in Brattleboro Rats by Acute Administration of Clozapine and a Neurotensin Agonist, but not Haloperidol: a Potential Predictive Model for Novel Antipsychotic Effects-Reference-Cited by-同舟云学术

Reversal of Sensorimotor Gating Deficits in Brattleboro Rats by Acute Administration of Clozapine and a Neurotensin Agonist, but not Haloperidol: a Potential Predictive Model for Novel Antipsychotic Effects

Published:2004-02-04 Issue:4 Volume:29 Page:731-738
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Feifel David,Melendez Gilia,Shilling Paul D

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300378.pdf

Reference41 articles.

1. Adachi DK, Kalivas PW, Schenk JO (1990). Neurotensin binding to dopamine. J Neurochem 54: 1321–1328.

2. Braff DL, Geyer MA (1990). Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47: 181–188.

3. Caceda R, Kinkead B, Nemeroff CB (2003). Do neurotensin receptor agonists represent a novel class of antipsychotic drugs? Semin Clin Neuropsychiatry 8: 94–108.

4. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 158: 518–526.

5. Cilia J, Reavill C, Hagan JJ, Jones DN (2001). Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl) 156: 327–337.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hippocampal chloride transporter KCC2 contributes to excitatory GABA dysregulation in the developmental rat model of schizophrenia;Journal of Chemical Neuroanatomy;2021-12

2. Ameliorating schizophrenia-like symptoms in vasopressin deficient male Brattleboro rat by chronic antipsychotic treatment;European Journal of Pharmacology;2021-10

3. Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders;Current Drug Metabolism;2017-04-11

4. Modeling Schizophrenia in Animals;Animal Models for the Study of Human Disease;2017

5. Antipsychotic-like effects of a neurotensin receptor type 1 agonist;Behavioural Brain Research;2016-05